Results 231 to 240 of about 78,667 (269)

A rapid method to reduce drug interferences for antibody measurements in pegunigalsidase alfa-treated patients with Fabry disease. [PDF]

Front Immunol
Lenders M, Rudolph E, Rudnicki M, Cybulla M, Brand E.   +4 more
europepmc   +1 more source

RNA-based therapeutic interventions for the management of Anderson-Fabry disease. [PDF]

Mol Ther Nucleic Acids
Cagnin S.
europepmc   +1 more source

Adequate hemodialysis does not compromise the cardioprotective effect of agalsidase alfa on patients with Fabry disease: a case report. [PDF]

J Med Case Rep
Wei X, Jiang S, Zhuo L, Jiang H, Li W.
europepmc   +1 more source

Discovery and Preliminary Characterization of Lactose-Transforming Enzymes in Ewingella americana L47: A Genomic, Biochemical, and In Silico Approach. [PDF]

Int J Mol Sci
Rivero K, Valenzuela R, Rivero I, General P, Neira N, Contreras F, Alzate-Morales J, Muñoz-Villagrán C, Vera C, Arenas-Salinas M, Arenas F.   +10 more
europepmc   +1 more source

Liquid Crystal Monomers and Their Mixtures Alter Nuclear Receptor Signaling and Promote Adipogenesis In Vitro.

Endocrinology
Heldman SM, Eccles KM, Kassotis CD.
europepmc   +1 more source

Correction to: "Liquid Crystal Monomers and Their Mixtures Alter Nuclear Receptor Signaling and Promote Adipogenesis In Vitro".

Endocrinology
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alpha‐Galactosidase A Activity Levels in Turkish Male Hemodialysis Patients

Therapeutic Apheresis and Dialysis, 2012
AbstractFabry disease is an X‐linked lysosomal storage disorder due to deficient activity of alpha‐galactosidase A (α‐Gal A) leading to renal insufficiency in males. The aim of present study was to investigate the level of α‐Gal A activity and to determine the prevalence of Fabry disease in a Turkish male hemodialysis population. The activity of plasma
Sozmen, Eser, Basci, Ali, Coker, Mahmut, Duman, Soner, Ucar, Sema Kalkan   +4 more
openaire   +2 more sources

Novel alpha-galactosidase A mutation in a female with recurrent strokes

Clinical Biochemistry, 2012
Anderson-Fabry disease (AFD) is an X-linked inborn error of glycosphingolipid catabolism resulting from the deficient activity of the lysosomal exoglycohydrolase, a-galactosidase A. The complete genomic and cDNA sequences of the human alpha-galactosidase A gene have been determined and to date, several disease-causing alpha-galactosidase A mutations ...
Tuttolomondo A, Duro G, Miceli S, Di Raimondo D, Pecoraro R, Serio A, Albeggiani G, Nuzzo D, Iemolo F, Pizzo F, Sciarrino S, Licata G, Pinto A   +12 more
openaire   +3 more sources

Plasma α-galactosidase A: Properties and comparisons with tissue α-galactosidases

Biochimica et Biophysica Acta (BBA) - Enzymology, 1978
The human plasma form of alpha-galactosidase A (alpha-D-galactoside galactohydrolase, EC 3.2.1.22) was highly purified and exhibited apparent Km values of 1.9 mM with 4-methylumbelliferyl-alpha-D-galactopyranoside and 0.23 mM with globotriglycosylceramide.
D F, Bishop, C C, Sweeley
openaire   +2 more sources